Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-109797
Filing Date
2016-03-21
Accepted
2016-03-21 17:02:02
Documents
2
Period of Report
2016-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2172
2 POA DOCUMENT poa.txt EX-24.3_644038 3956
  Complete submission text file 0001209191-16-109797.txt   7546
Mailing Address C/O IMMUNOGEN, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
JUNIUS DANIEL M (Reporting) CIK: 0001094159 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0627
Type: 3 | Act: 34 | File No.: 001-36177 | Film No.: 161519227

Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations